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Abstract
Late gadolinium enhanced (LGE) cardiovascular magnetic resonance (CMR) has proven to be the
gold standard for viability assessment. LGE CMR is also useful for identifying the nature of cardiac
masses or lesions. We report a case of a rare primary cystic tumor of the atrioventricular node, in
which CMR proved to be valuable.
Background
Although primary cystic tumor of the atrioventricular
node is very rare and classified as benign [1], it may lead
to significant morbidity and mortality due to obstruction,
arrhythmias and embolism [2]. Cystic tumors usually
consist of multi-cystic nodules and are located in the
region of the atrioventricular (AV) node [2]. It is rarely
found in the literature[3]. This is a difficult tumor to iden-
tify on non-invasive studies or clinical findings, especially
to distinguish from myxomas. Treatment requires imme-
diate surgery. We have identified three [4-6] previous sur-
gical successes with this otherwise almost invariably fatal
cardiac tumor. The use of cardiovascular magnetic reso-
nance (CMR) and computed tomography (CT) have been
helpful in identifying tumors occurring in the intra-atrial
septum and the AV node. Paniaga et al [4] included an
axial T1 weighted CMR, which is similar to the current
case but gives no information about LGE. The other [5]
gives no CMR information.
Case presentation
The patient, a 42-year old female, was referred for CMR
with suspected atrial myxoma and the confirmation was
needed for pre-surgical evaluation. She presented with
episodes of syncope, mitral valve prolapse and suspected
atrial myxoma. She had four successful pregnancies, how-
ever, developed shortness of breath about 1 month after
the birth of her fourth infant. An electrocardiogram (ECG)
was performed with results indicating sinus rhythm with
first degree AV block and PR interval of nearly 400 ms, an
LV ejection fraction (EF) of 50%, mildly dilated left ven-
tricle (LV = 58 mm and 42 mm), left atrial enlargement
and mitral regurgitation. Two weeks after the ECG study,
the patient was admitted to the hospital due to recurrent
syncope and a repeated ECG showed abnormal AV node
function and the subsequently had a dual chamber pace-
maker implanted. About a month after the implantation,
the patient had persistent swelling and yellowish dis-
charge due to infection in the peripherally inserted central
catheter (PICC) line and the pacemaker had to be
removed. An echocardiogram revealed a myxomatous
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mass in the right atrium. The patient was then scheduled
for surgery to remove the mass, with CMR preceding the
surgery for confirmation of the right atrial myxoma [7].
The patient was scanned in a 1.5 T clinical scanner (Gen-
eral Electric, Milwaukee, WI) using a 4-element phased
array coil and gated by a 4-lead electrocardiogram (ECG).
Two doses of gadopentetate dimeglumine (Magnevist,
Berlex, Wayne, NJ) were injected (the first, 0.05 mL/kg at
2 mL/second for perfusion imaging and the second, 0.1
mL/kg for late gadolinium enhancement) using a Spectrus
power injector (Medrad, Indianola, PA). The protocol
used is as follows: (1) sagittal localizer using fast spoiled
grass (fSPGR); (2) long axis localizer using Fast Imaging
Employing Steady State Acquisition (FIESTA); (3) short
axis using FIESTA; (4) perfusion imaging using fast gradi-
ent echo-echo train (FGRE-ET); (5) cine radial views using
FIESTA; (6) Late Gadolinium Enhancement (LGE)
approximately 10 minutes post-intravenous injection. All
acquisitions, except for the perfusion study, were per-
formed with breath-holding and the entire exam was
accomplished in 45 minutes. The data was analyzed and
quantified using Advantage Workstation (GE LX, Milwau-
kee, WI) and MASS Analysis Plus software (MEDIS, Neth-
erlands).
The standard imaging sequences revealed a hypointense
cardiac mass (Figure 1), measuring 2.5 × 1.5 cm2, located
in the right atrium (RA) on the atrial-septal wall immedi-
ately above the medial leaflet of the tricuspid valve. Fur-
thermore, there were no changes in the size of the mass
during systole and diastole phases. LGE revealed an-
enhancing mass (Figure 2), consistent with a myxoma.
There is also an atrial septal defect (ASD) (Figure 3) with
left to right shunting which presented as two "jets" supe-
rior and inferior to the mass. A very modest mitral regur-
gitant jet was noted (Figure 4), with significant left atrial
enlargement and slight increase in end diastolic LV vol-
ume (EDV = 134 ml; normal = 98–127). The patient's
ejection fraction (EF = 60%), stroke volume (SV = 80 ml)
and cardiac index (CI = 2.5 L/min/m2) were in the normal
range. Differential diagnosis included right atrial myxoma
due to isointensity on FSPGR images, hyperintensity on
LGE images with heterogeneous contrast enhancement
[8]. However, the mass was 2.5 cm in diameter, compared
to myxomas which are usually 6 cm in size, and was
hypointense on FIESTA images. Combining this informa-
tion with the histopathology report, the final diagnosis is
a right atrial cystic tumor of the AV node.
A surgical sternotomy and excision of the atrial tumor was
performed and findings include an atrial-septal defect and
a golf ball size tumor measuring 2 × 3 cm2 between the
coronary sinus and the tricuspid valve annulus. The tricus-
pid valve was preserved and the roof of the coronary sinus
was protected. The surgical area was patched using peri-
cardial patch and the atrial septal defect was also closed. It
was noted that the patient was in heart block postopera-
tively. A few days following the resection, the patient
received a new dual chamber pacemaker. The patient
made a full and uneventful recovery.
Four chamber long axis view revealing the tumor at the atri- oventricular node Figure 1
Four chamber long axis view revealing the tumor at 
the atrioventricular node.
Late gadolinium enhancement of the tumor Figure 2
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A sample of the tumor was sent for pathology investiga-
tion. The specimen had a large amount of orange/brown
thickened debris which was then sent to microbiology for
aerobic, bacterial and fungal studies. The histology report
indicated that the tumor was filled with abundant brown
amorphous material. It consisted of multiple cysts (Figure
5) of variable sizes and nests of cells with a fibrotic back-
ground interspersed with chronic inflammatory cells. The
cysts were lined with squamous cells with abundant kerat-
inous debris within the cysts. The morphologic appear-
ance was consistent with cystic tumor of the
atrioventricular node. Since the patient developed symp-
toms during her pregnancy, immunostains for estrogen
and progesterone receptors (Figure 6) were also per-
formed. This was strongly positive for estrogen receptors
and focally positive for progesterone receptors, indicating
that the tumor might have been progressive during the
pregnancy stage due to increase levels of hormones. A
study by Letterie et al [9] found a benign cystic atrio-ven-
tricular nodal tumor treated with a long-acting gonadotro-
pin releasing hormone (GnRH) decreased in size.
However, with the addition of a combination of estrogen
and progestin, the cyst gradually increased in size and pro-
gressed even after the discontinuation of all therapy. This
study and our findings suggest that there might be a cor-
relation between the progression of such tumors and the
levels of hormones present.
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Four chamber long axis view demonstrating an atrial-septal  defect with left-to-right shunting Figure 3
Four chamber long axis view demonstrating an 
atrial-septal defect with left-to-right shunting.
Three chamber view of the left atrium, left ventricle and right  ventricle demonstrating modest mitral incompetence and  large left atrium Figure 4
Three chamber view of the left atrium, left ventricle 
and right ventricle demonstrating modest mitral 
incompetence and large left atrium.
Histology image of the tumor shows cysts of variable sizes  filled with keratinous debris and nests of epithelial cells with  squamous differentiation Figure 5
Histology image of the tumor shows cysts of variable 
sizes filled with keratinous debris and nests of epithe-
lial cells with squamous differentiation.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Cardiovascular Magnetic Resonance 2009, 11:13 http://www.jcmr-online.com/content/11/1/13
Page 4 of 4
(page number not for citation purposes)
performed and analyzed the histopathology of the tumor.
JG and BDR aided in the analysis of the MRI and the diag-
nosis of the tumor. All authors read and approved the
final manuscript.
Acknowledgements
(1) The Pfeiffer Foundation Grant. (2) This paper is presented in the occa-
sion of the 100th birthday of Dr. Richard Bing.
References
1. Colucci WS, Schoen FJ: "Primary Tumors of the Heart." Heart
Disease – A Textbook of Cardiovascular Medicine.  Volume 2.
WB Saunders Company, Philadelphia; 2001:115. 
2. Krombach GA, Saeed M, Higgins CB: "Myocardial and Pericardial
Diseases – Pericardial Tumors." Cardiovascular MRI & MRA.
Lippincott Williams & Wilkins, Philadelphia; 2003:117-119. 
3. Wolf PL, Bing R: The Smallest Tumor Which Causes Sudden
Death.  JAMA 1965, 194:674-675.
4. Paniagua JR, Sadaba JR, Davidson LA, Munsch CM: Cystic tumour of
the atrioventricular nodal region: report of a case success-
fully treated with surgery.  Heart 2000, 83:E6.
5. Balasunderan S, Halees AS, Duran C: Mesothelioma of the atrio-
ventricular node: first successful follow-up after excision.  Eur
Heart J 1992, 13(5):718-719.
6. Kaminishi Y, Watanabe Y, Nakata H, Shimokama T, Jikuya T: Cystic
tumor of the atrioventricular nodal region.  Jpn J Thorac Cardio-
vasc Surg 2002, 50(1):37-39.
7. Luna A, Ribes R, Caro P, Vida J, Erasmus JJ: Evaluation of cardiac
tumors with magnetic resonance imaging.  Eur Radiol 2005,
15:1446-1455.
8. Wintersperger BJ, Becker CR, Gulbins H, Knez A, Bruening R, Heuck
A, Reiser MF: Tumors of cardiac valves: imaging findings in
magnetic resonance imaging, electron beam computed
tomography, and echocardiography.  Eur Radiol 2000,
10(3):443-449.
9. Letterie GS, Yon JL: Use of a long-acting GnRH agonist for
benign cystic mesothelioma.  Obstet Gynecol 1995, 85(5 pt
2):901-903.
The tumor was strongly positive for estrogen and focally  positive for progesterone receptor Figure 6
The tumor was strongly positive for estrogen and 
focally positive for progesterone receptor.